A JAPANESE PHASE III OPEN-LABEL STUDY TO ASSESS SAFETY AND EFFICACY OF PALONOSETRON (PALO) 0.75 MG IV FOR PREVENTING CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING (CINV) IN REPEATED CYCLES OF HIGHLY EMETOGENIC CHEMOTHERAPY. PALO JAPANESE COOPERATIVE STUDY GROUP